Waldenström′s macroglobulinemia: Two malignant clones in a monoclonal disease? Molecular background and clinical reflection-Reference-Cited by-同舟云学术

Waldenström′s macroglobulinemia: Two malignant clones in a monoclonal disease? Molecular background and clinical reflection

Published:2017-10-10 Issue:6 Volume:99 Page:469-478
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Growková Kateřina¹²^ORCID,Kryukova Elena²³,Kufová Zuzana²⁴,Filipová Jana¹²,Ševčíková Tereza¹²,Říhová Lucie⁵,Kaščák Michal³,Kryukov Fedor²³,Hájek Roman²³

Affiliation:

1. Department of Biology and Ecology; Faculty of Science; University of Ostrava; Ostrava Czech Republic

2. Department of Clinical Studies; Faculty of Medicine; University of Ostrava; Ostrava Czech Republic

3. Department of Haemato-Oncology; University Hospital Ostrava; Ostrava Czech Republic

4. Department of Experimental Biology; Faculty of Science; Masaryk University; Brno Czech Republic

5. Department of Clinical Haematology; University Hospital Brno; Brno Czech Republic

Funder

Ministerstvo Zdravotnictví Ceské Republiky

Ministerstvo Školství, Mládeže a Tělovýchovy

Institutional Development Plan of University of Ostrava

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12959/fullpdf

Reference72 articles.

1. Multiparameter flow cytometry for the identification of the Waldenstrom's clone in IgM-MGUS and Waldenstrom's Macroglobulinemia: new criteria for differential diagnosis and risk stratification;Paiva;Leukemia,2014

2. Immunophenotypic analysis of Waldenstrom's macroglobulinemia;San;Semin Oncol,2003

3. Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenstrom's macroglobulinemia;Morice;Mod Pathol,2009

4. Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells;Remstein;Semin Oncol,2003

5. Whole genome sequencing reveals a widely expressed mutation (MYD88 L265P) with oncogenic activity in Waldenstrom's Macroglobulinemia;Treon;Blood,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial;Nature Communications;2024-08-11

2. First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma;2023-09-21

3. Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia;Journal of Translational Medicine;2022-12-09

4. Transformation to diffuse large B-cell lymphoma with germinal center B-cell like subtype and discordant light chain expression in a patient with Waldenström macroglobulinemia/lymphoplasmacytic lymphoma;International Journal of Hematology;2021-04-27

5. Identification of a Candidate Gene Set Signature for the Risk of Progression in IgM MGUS to Smoldering/Symptomatic Waldenström Macroglobulinemia (WM) by a Comparative Transcriptome Analysis of B Cells and Plasma Cells;Cancers;2021-04-12